HPSE and carcinoma of esophagus: Nevertheless, recent epidemiological studies have indicated that serum resistin is significantly elevated in patients with breast, gastric, colorectal, endometrial and esophageal carcinomas [57] clearly suggesting that heparanase and resistin are associated with the tumor and its microenvironment and can possibly co-operate and drive tumor progression.